Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 7/20 | 0.67 |
| ▸ | F3 | P13726 | 7/20 | 0.67 |
| ▸ | PPARG | P37231 | 7/20 | 0.67 |
| ▸ | PPARD | Q03181 | 6/20 | 0.67 |
| ▸ | PPARA | Q07869 | 6/20 | 0.67 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.67 |
| ▸ | ESR1 | P03372 | 1/20 | 0.67 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.67 |
| ▸ | CASP6 | P55212 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.65 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.65 |
| ▸ | MAPT | P10636 | 5/20 | 0.65 |
| ▸ | LMNA | P02545 | 4/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.65 |
| ▸ | HPGD | P15428 | 3/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12000570 | 1.00 | F7 (0.67) | F7F3PPARGPPARDPPARA | |
| SCHEMBL466115 | 1.00 | F7 (0.67) | F7F3PPARGPPARDPPARA | |
| SCHEMBL12381102 | 0.98 | ALDH1A1 (0.68) | F7F3PPARGPPARDPPARA | |
| SCHEMBL2465250 | 0.98 | ALDH1A1 (0.68) | F7F3PPARGPPARDPPARA | |
| SCHEMBL2370643 | 0.98 | ALDH1A1 (0.68) | F7F3PPARGPPARDPPARA | |
| SCHEMBL25318588 | 0.98 | ALDH1A1 (0.68) | F7F3PPARGPPARDPPARA | |
| SCHEMBL2370641 | 0.98 | ALDH1A1 (0.68) | F7F3PPARGPPARDPPARA | |
| SCHEMBL25318584 | 0.98 | ALDH1A1 (0.68) | F7F3PPARGPPARDPPARA | |
| SCHEMBL28463803 | 0.98 | ALDH1A1 (0.68) | F7F3PPARGPPARDPPARA | |
| SCHEMBL5058604 | 0.98 | ALDH1A1 (0.68) | F7F3PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4294375-A1 | METHODS OF LOADING EXTRACELLULAR VESICLES | Lonza Sales AG (CH) | 2023-12-27 | — | — | EP | claimed |
| US-20220354963-A1 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | CODIAK BIOSCIENCES, INC. (US) | 2022-11-10 | — | — | US | claimed |
| WO-2022178147-A1 | METHODS OF LOADING EXTRACELLULAR VESICLES | CODIAK BIOSCIENCES, INC. (US) | 2022-08-25 | — | — | WO | claimed |
| EP-4013457-A1 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | Codiak BioSciences, Inc. (US) | 2022-06-22 | — | — | EP | claimed |
| WO-2021030777-A1 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | CODIAK BIOSCIENCES, INC. (US) | 2021-02-18 | — | — | WO | claimed |
| EP-2120586-B1 | ADJUVANTS AND METHODS OF USING THEM | ARCHER DANIELS MIDLAND CO (US) | 2018-07-04 | — | — | EP | claimed |
| US-20160324150-A1 | ADJUVANTS AND METHODS OF USING THEM | ARCHER DANIELS MIDLAND COMPANY | 2016-11-10 | — | — | US | claimed |
| US-9416065-B2 | Adjuvants and methods of using them | ARCHER DANIELS MIDLAND COMPANY (US) | 2016-08-16 | — | — | US | claimed |
| US-8425784-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2013-04-23 | — | — | US | claimed |
| EP-2120586-A2 | ADJUVANTS AND METHODS OF USING THEM | Archer-Daniels-Midland Company (US) | 2009-11-25 | — | — | EP | claimed |
| US-7491854-B2 | Enzymatic method of making aldehydes from fatty acids | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2009-02-17 | — | — | US | claimed |
| WO-2008100896-A2 | ADJUVANTS AND METHODS OF USING THEM | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2008-08-21 | — | — | WO | claimed |
| US-20080194410-A1 | acidificers propionic acid, methyl acetic acid, acetic acid, lactic acid, fumaric acid, citric acid, phosphoric acid mixed with lecithin emulsifier; nonphenolic nonionic surfactant such as ethoxylated monolycerides, fatty acid ethoxylates, polyoxyethylene alkyl ethers, polyoxyethylene alkyl esters; water | ARCHER DANIELS MIDLAND COMPANY | 2008-08-14 | — | — | US | claimed |
| WO-2007142784-A1 | ENZYMATIC METHOD OF MAKING ALDEHYDES FROM FATTY ACIDS | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2007-12-13 | — | — | WO | claimed |
| US-20070281345-A1 | Enzymatic Method of Making Aldehydes from Fatty Acids | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2007-12-06 | — | — | US | claimed |
| US-12611415-B2 | Methods and compounds for treatment of metabolic disease | MONASH UNIVERSITY (AU) | 2026-04-28 | — | — | US | disclosed |
| US-12594339-B2 | Lipid prodrugs of JAK inhibitors and uses thereof | SEAPORT THERAPEUTICS, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-5219733-A | Reacting sterol or fatty alcohol with fatty acid or ester in contact with microorganism-derived lipase in water or mixture of water and organic solvent | YOSHIKAWA OIL & FAT CO., LTD. (JP) | 1993-06-15 | — | — | US | disclosed |
| EP-0195311-B1 | PROCESS FOR PREPARING FATTY ACID ESTERS | NIPPON FINE CHEMICAL CO., LTD. (JP) | 1990-06-27 | — | — | EP | disclosed |
| EP-0195311-A2 | Process for preparing fatty acid esters | NIPPON FINE CHEMICAL CO., LTD. (JP) | 1986-09-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12611415-B2 | Methods and compounds for treatment of metabolic disease | SUCNR1, GPR119, SLC2A1 | F7 3751/4885F3 2821/4885PPARG 78/4885 |
| US-20220354963-A1 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | EXOSC5, EXOSC4, EXOSC10 | F7 4406/4885F3 4311/4885PPARG 4131/4885 |
| US-12594339-B2 | Lipid prodrugs of JAK inhibitors and uses thereof | JAK1, JAK3, JAK2 | F7 1144/4885F3 570/4885PPARG 1063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.